Kestrel Therapeutics

Allston, MA · Founded 2020 · Privately Held (backing)

Developer of oncological drugs designed to treat RAS-driven cancers and bring a new therapy to cancer's frequently mutated oncogenic target. Kestrel Therapeutics is based in Allston, MA and was founded in 2020. Its last reported valuation was $17.7 million in Jan 2022. It has raised $20.7 million across 3 recorded rounds; the latest was a $5 million early-stage round in Jul 2025.

Last reported valuation
$17.7M
Oct 2026
Priced at
—
Total raised
$20.7M
Last round
Early Stage VC
Jul 2025
How much has Kestrel Therapeutics raised?
$20.7Macross 3 recorded rounds · Dec 2021 – Jul 2025

Most recently, Kestrel Therapeutics raised $5.0M in its Early Stage VC (Jul 2025).

Free account
More of Kestrel Therapeutics with a free account
  • ·Watch Kestrel Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Kestrel Therapeutics round by round

3 rounds
Jul 2025Early Stage VC$5.0MSEC filing▮
6 investors participated
Feb 2025Early Stage VC$8.0MSEC filing▮
7 investors participated
Dec 2021Early Stage VC$7.5MSEC filing▮
6 investors participated

How much has Kestrel Therapeutics raised?

Kestrel Therapeutics has raised $20.7 million across 3 recorded rounds since 2021. The largest was an $8 million early-stage round in Feb 2025; the most recent was a $5 million early-stage round in Jul 2025.

Kestrel Therapeutics has filed 4 Form Ds with the SEC since 2021, most recently in Aug 2025 ($5 million sold to 6 investors).

Kestrel Therapeutics investors

5 investors are on record for Kestrel Therapeutics, including Harvard Innovation Launch Lab, S32, Cormorant Asset Management and Pfizer Ventures. The early-stage round in Jul 2025 drew 6 investors.

For fundraisers
Raising for a company like Kestrel Therapeutics?

5 investors have backed Kestrel Therapeutics.

See all 5 investors →

Frequently asked about Kestrel Therapeutics

How much has Kestrel Therapeutics raised?
Kestrel Therapeutics has raised $20.7M in total across 3 recorded funding rounds.
When was Kestrel Therapeutics's last funding round?
Kestrel Therapeutics's most recent recorded round was Early Stage VC in Jul 2025, raising $5.0M.